Cancer Treatment Holdings, Inc.
CTHZ
OTC PK
| 02/28/2003 | 11/30/2002 | 08/31/2002 | 05/31/2002 | 02/28/2002 | |
|---|---|---|---|---|---|
| Revenue | -- | 225.00% | -32.97% | -40.68% | -- |
| Total Other Revenue | -- | -55.91% | -39.51% | 20.27% | -52.52% |
| Total Revenue | -- | 35.04% | -36.05% | -117.50% | 63.31% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 35.04% | -36.05% | -117.50% | 63.31% |
| SG&A Expenses | -15.28% | 83.00% | 61.18% | 126.71% | 24.40% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 23.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.67% | 80.23% | 57.47% | 120.04% | 24.37% |
| Operating Income | -5.67% | -85.33% | -84.11% | -143.42% | -17.68% |
| Income Before Tax | -499.10% | -98.82% | -61.16% | -224.32% | 1.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -499.10% | -98.82% | -61.16% | -224.32% | 1.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -499.10% | -98.82% | -61.16% | -224.32% | 1.12% |
| EBIT | -5.67% | -85.33% | -84.11% | -143.42% | -17.68% |
| EBITDA | -5.97% | -88.62% | -90.86% | -151.89% | -17.38% |
| EPS Basic | -499.62% | -98.87% | -60.87% | -224.52% | 1.12% |
| Normalized Basic EPS | -12.65% | -98.20% | -61.24% | -224.74% | 1.19% |
| EPS Diluted | -499.62% | -98.87% | -60.87% | -224.52% | 1.12% |
| Normalized Diluted EPS | -12.65% | -98.20% | -61.24% | -224.74% | 1.19% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
